Luminal (ER+ve and/or PgR+ve >=1%) invasive breast cancer or ductal carcinoma in situ research hub

Time restricted Eating And Metformin (TEAM) in invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS). A randomized, phase IIb, window of opportunity presurgical trial.

This study looks at how a special eating plan (time-restricted eating) combined with a common diabetes medicine (metformin) might affect breast cancer before surgery. It's for women with certain types of breast cancer or pre-cancerous cells to see if these treatments can slow down cell growth.